A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
He Li(Central South University), Ke Zhou(Zhejiang Chinese Medical University), Ziyu Dai(Central South University), Hui Cao(Guangdong Ocean University), Wantao Wu(Central South University), Peng Luo(Zhujiang Hospital), Gelei Xiao(Central South University), Shi Chen(Fujian Medical University), Zeyu Wang(Anhui University), Jian Zhang(Zhujiang Hospital), Kaiyue Wang(Central South University), Zaoqu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Quan Cheng(Central South University), Yun Peng(Chinese Academy of Sciences)
Cited by 10
Related Papers
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
|Scientific Reports|2019|426